Pituitary Stalk Interruption Syndrome (PSIS) Market is expected to reach US$ 2.4 billion by 2032 | Major Companies – AnkeBio Co., Ltd, Novo Nordisk, Pfizer Inc.

Openpr.com

Image Credit: Openpr.com

Please find more details at Openpr.com

Summary

Market Size and Growth:The Global Pituitary Stalk Interruption Syndrome (PSIS) Market Size reached US$ 1.2 billion in 2024 and is expected to reach US$ 2.4 billion by 2032, growing with a CAGR of 7.5% during the forecast period 2025-2032. The

Source: Openpr.com

Read More

(0)

Exclusive AI-Powered News Insights (For Members only)

Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!